Cheng Lu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Obstetrics and Gynecology top 5%
- Pregnancy and preeclampsia studies
Papers in
-
- RNA modifications and cancer 7
- Epigenetics and DNA Methylation 7
- Circular RNAs in diseases 5
- Advanced biosensing and bioanalysis techniques 5
-
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 6
- Co-authors
- Mingming Lv (8 shared papers)Sheng Gao (9 shared papers)Jianming Wang (9 shared papers)Jingjing Ma (6 shared papers)Fengliang Wang (7 shared papers)Fengliang Wang (6 shared papers)Nan Xu (3 shared papers)Xun Lu (5 shared papers)
- Journals
- Tumor Biology (5 papers)PLoS ONE (4 papers)Biomedicine & Pharmacotherapy (3 papers)Breast Cancer Research and Treatment (3 papers)Journal of Cellular Physiology (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Cheng Lu
56 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 111
- Cancer Research 381
- Obstetrics and Gynecology 123
- Molecular Biology 659
- Oncology 238
- Genetics 225
Countries citing papers authored by Cheng Lu
This map shows the geographic impact of Cheng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Lu more than expected).
Fields of papers citing papers by Cheng Lu
This network shows the impact of papers produced by Cheng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Lu. The network helps show where Cheng Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Cheng Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 128 | |
| 2 | 2008 | 85 | |
| 3 | 2008 | 78 | |
| 4 | 2018 | 62 | |
| 5 | 2015 | 60 | |
| 6 | 2015 | 53 | |
| 7 | 2013 | 48 | |
| 8 | 2014 | 48 | |
| 9 | 2014 | 46 | |
| 10 | 2013 | 38 | |
| 11 | 2014 | 34 | |
| 12 | 2014 | 31 | |
| 13 | 2017 | 30 | |
| 14 | 2009 | 29 | |
| 15 | 2020 | 29 | |
| 16 | 2008 | 28 | |
| 17 | 2017 | 27 | |
| 18 | 2011 | 27 | |
| 19 | 2013 | 26 | |
| 20 | 2014 | 22 |
About Cheng Lu
Cheng Lu is a scholar working on Molecular Biology, Cancer Research, Genetics, Oncology and Surgery, having authored 58 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (7 papers), Epigenetics and DNA Methylation (7 papers), MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (5 papers), Advanced biosensing and bioanalysis techniques (5 papers), BRCA gene mutations in cancer (3 papers) and Esophageal and GI Pathology (3 papers). The work is most often cited by research in Cancer Research (381 citations), Obstetrics and Gynecology (123 citations), Molecular Biology (659 citations), Oncology (238 citations) and Genetics (225 citations). Cheng Lu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Mingming Lv, Sheng Gao, Jianming Wang, Jingjing Ma, Fengliang Wang, Fengliang Wang, Nan Xu, Xun Lu, Wei Long and Yan Lv. Their work appears in journals such as Tumor Biology, PLoS ONE, Biomedicine & Pharmacotherapy, Breast Cancer Research and Treatment and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.